Cargando…

Hexokinase 2 displacement from mitochondria‐associated membranes prompts Ca(2+)‐dependent death of cancer cells

Cancer cells undergo changes in metabolic and survival pathways that increase their malignancy. Isoform 2 of the glycolytic enzyme hexokinase (HK2) enhances both glucose metabolism and resistance to death stimuli in many neoplastic cell types. Here, we observe that HK2 locates at mitochondria‐endopl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ciscato, Francesco, Filadi, Riccardo, Masgras, Ionica, Pizzi, Marco, Marin, Oriano, Damiano, Nunzio, Pizzo, Paola, Gori, Alessandro, Frezzato, Federica, Chiara, Federica, Trentin, Livio, Bernardi, Paolo, Rasola, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332982/ https://www.ncbi.nlm.nih.gov/pubmed/32383545 http://dx.doi.org/10.15252/embr.201949117

Ejemplares similares

Hexokinase 2 in Cancer: A Prima Donna Playing Multiple Characters
por: Ciscato, Francesco, et al.
Publicado: (2021)

Metabolic Plasticity of Tumor Cell Mitochondria
por: Cannino, Giuseppe, et al.
Publicado: (2018)

Hexokinase II Detachment from Mitochondria Triggers Apoptosis through the Permeability Transition Pore Independent of Voltage-Dependent Anion Channels
por: Chiara, Federica, et al.
Publicado: (2008)

Tumor growth of neurofibromin-deficient cells is driven by decreased respiration and hampered by NAD(+) and SIRT3
por: Masgras, Ionica, et al.
Publicado: (2022)

The Chaperone TRAP1 As a Modulator of the Mitochondrial Adaptations in Cancer Cells
por: Masgras, Ionica, et al.
Publicado: (2017)

Loosening ER–Mitochondria Coupling by the Expression of the Presenilin 2 Loop Domain
por: Rossini, Michela, et al.
Publicado: (2021)

The mitochondrial chaperone TRAP1 regulates F-ATP synthase channel formation
por: Cannino, Giuseppe, et al.
Publicado: (2022)

GSK-3 and mitochondria in cancer cells
por: Chiara, Federica, et al.
Publicado: (2013)

Defining the molecular mechanisms of the mitochondrial permeability transition through genetic manipulation of F-ATP synthase
por: Carrer, Andrea, et al.
Publicado: (2021)

Protein Phosphorylation and Redox Status: An as Yet Elusive Dyad in Chronic Lymphocytic Leukemia
por: Pagano, Mario Angelo, et al.
Publicado: (2022)

Contribution of the CK2 Catalytic Isoforms α and α’ to the Glycolytic Phenotype of Tumor Cells
por: Zonta, Francesca, et al.
Publicado: (2021)

Hexokinases inhibit death receptor–dependent apoptosis on the mitochondria
por: Lauterwasser, Joachim, et al.
Publicado: (2021)

A study on the two binding sites of hexokinase on brain mitochondria
por: Golestani, Abolfazl, et al.
Publicado: (2007)

Sarcoplasmic Reticulum-Mitochondria Kissing in Cardiomyocytes: Ca(2+), ATP, and Undisclosed Secrets
por: Rossini, Michela, et al.
Publicado: (2020)

Mitofusin‐2 knockdown increases ER–mitochondria contact and decreases amyloid β‐peptide production
por: Leal, Nuno Santos, et al.
Publicado: (2016)

Myotonic dystrophy protein kinase (DMPK) prevents ROS-induced cell death by assembling a hexokinase II-Src complex on the mitochondrial surface
por: Pantic, B, et al.
Publicado: (2013)

P054: The Kinase CK2 is deregulated and targetable in classical Hodgkin Lymphoma
por: Visentin, Andrea, et al.
Publicado: (2022)

HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia
por: Laquatra, Claudio, et al.
Publicado: (2021)

Amyloid-β Triggers the Release of Neuronal Hexokinase 1 from Mitochondria
por: Saraiva, Leonardo M., et al.
Publicado: (2010)

The hexokinase “HKDC1” interaction with the mitochondria is essential for liver cancer progression
por: Khan, Md. Wasim, et al.
Publicado: (2022)

SUMOylation controls the binding of hexokinase 2 to mitochondria and protects against prostate cancer tumorigenesis
por: Shangguan, Xun, et al.
Publicado: (2021)

Bendamustine plus rituximab is an effective first-line treatment in hairy cell leukemia variant: a report of three cases
por: Visentin, Andrea, et al.
Publicado: (2017)

Mitofusin 2: from functions to disease
por: Filadi, Riccardo, et al.
Publicado: (2018)

Expression of the p66Shc protein adaptor is regulated by the activator of transcription STAT4 in normal and chronic lymphocytic leukemia B cells
por: Cattaneo, Francesca, et al.
Publicado: (2016)

Is It Still Possible to Think about HSP70 as a Therapeutic Target in Onco-Hematological Diseases?
por: Mouawad, Nayla, et al.
Publicado: (2023)

SERPINB3 protects from oxidative damage by chemotherapeutics through inhibition of mitochondrial respiratory complex I
por: Ciscato, Francesco, et al.
Publicado: (2013)

Modulation of hexokinase association with mitochondria analyzed with quantitative three-dimensional confocal microscopy
Publicado: (1991)

Defective autophagy and Alzheimer’s disease: is calcium the key?
por: Filadi, Riccardo, et al.
Publicado: (2019)

Key Signalling Molecules in Aging and Neurodegeneration
por: Filadi, Riccardo, et al.
Publicado: (2022)

Hexokinase 2 as oncotarget
por: Patra, Krushna C., et al.
Publicado: (2013)

Gold(III)–pyrrolidinedithiocarbamato Derivatives as Antineoplastic Agents**
por: Nardon, Chiara, et al.
Publicado: (2015)

Lights and Shade of Next-Generation Pi3k Inhibitors in Chronic Lymphocytic Leukemia
por: Visentin, Andrea, et al.
Publicado: (2020)

High glucose induces apoptosis of HUVECs in a mitochondria-dependent manner by suppressing hexokinase 2 expression
por: Zhang, Jia, et al.
Publicado: (2019)

Glycerophosphoinositol Promotes Apoptosis of Chronic Lymphocytic Leukemia Cells by Enhancing Bax Expression and Activation
por: Boncompagni, Gioia, et al.
Publicado: (2022)

p66Shc Deficiency in Chronic Lymphocytic Leukemia Promotes Chemokine Receptor Expression Through the ROS-Dependent Inhibition of NF-κB
por: Tatangelo, Vanessa, et al.
Publicado: (2022)

The Concerted Action of Mitochondrial Dynamics and Positioning: New Characters in Cancer Onset and Progression
por: Pendin, Diana, et al.
Publicado: (2017)

A precision therapeutic strategy for hexokinase 1-null, hexokinase 2-positive cancers
por: Xu, Shili, et al.
Publicado: (2018)

Hexokinase II–derived cell-penetrating peptide targets mitochondria and triggers apoptosis in cancer cells
por: Woldetsadik, Abiy D., et al.
Publicado: (2017)

In Chronic Lymphocytic Leukemia the JAK2/STAT3 Pathway Is Constitutively Activated and Its Inhibition Leads to CLL Cell Death Unaffected by the Protective Bone Marrow Microenvironment
por: Severin, Filippo, et al.
Publicado: (2019)

The isopeptidase inhibitor 2cPE triggers proteotoxic stress and ATM activation in chronic lymphocytic leukemia cells
por: Tomasella, Andrea, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0lnoqj3gt2eqft64qo82ecj884